Optimism may be increased by taking psychedelic compound psilocybin
Treatment and reversal learning task design. Credit: Translational Psychiatry (2024). DOI: 10.1038/s41398-024-03103-7

Monash University researchers have made a breakthrough in the study of psychedelics to treat disorders including major depression, demonstrating that rats given psilocybin exhibit increased optimism over time.

Psilocybin is a psychedelic compound found in magic mushrooms that has shown promise as a novel treatment for depression. However, the information processing mechanisms affected by psilocybin are not well understood.

Now, a cross-disciplinary team at Monash University has used computational modeling to demonstrate that rats given psilocybin display long-lasting, increased optimistic behavior to perform reward-based tasks.

The findings, published in Translational Psychiatry, suggest psilocybin may be helpful for addressing the core symptoms of major depression and other conditions characterized by reduced engagement and withdrawal.

Monash Ph.D. candidate Elizabeth (Beth) Fisher led the study, working with Professor Jakob Hohwy from the Monash Center for Consciousness and Contemplative Studies (M3CS) and Dr. Claire Foldi from the Monash Biomedicine Discovery Institute.

Professor Hohwy says the results are a promising step toward explaining the mechanisms of how psychedelics may work to change the brain and increase engagement after treatment. “Our team found that rats given psilocybin were more motivated to explore their environment and perform reward-based tasks.

“These exciting results show the mechanisms of how psilocybin may work to increase optimism in an animal model, which we hope may translate to humans as well.”

Fisher said that the study should motivate confirmation of these effects in human studies, adding, “Insights into the mechanisms of psilocybin allow us to unpack who may benefit from psychedelic therapies as well as who these treatments may not be beneficial for.

“With many people around the world affected by depression, our ultimate goal is to help build understanding of how psilocybin might be used to treat core symptoms people experience, such as diminished optimism, apathy and withdrawal from the world around them.”

More information:
Elizabeth L. Fisher et al, Psilocybin increases optimistic engagement over time: computational modelling of behaviour in rats, Translational Psychiatry (2024). DOI: 10.1038/s41398-024-03103-7

Provided by
Monash University


Citation:
Psilocybin may lead to increased optimism, rat study suggests (2024, October 8)
retrieved 8 October 2024
from https://medicalxpress.com/news/2024-10-psilocybin-optimism-rat.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.





Source link

Leave a Reply

Your email address will not be published. Required fields are marked *

Before you post, please prove you are sentient.

What is 7 * 6?

Explore More

Rushing or delaying decisions is linked to anxiety and depression in young people in South Africa

Credit: Pixabay/CC0 Public Domain Each day we make thousands of decisions, starting with what to have for breakfast and what to wear. We make so many decisions that we don’t

Safety and security: Study shines light on factors behind refugees’ resilience

A systematic review led by UNSW Professor Angela Nickerson has identified several strong protective and promotive factors that are associated with better mental health outcomes among refugee adults. “While exposure

Bright light therapy found to be effective for nonseasonal depressive disorders

Bright light therapy (BLT) is an effective adjunctive treatment for nonseasonal depressive disorder, according to a review published online Oct. 2 in JAMA Psychiatry. Artur Menegaz de Almeida, from the